The analysis reveals that the average cost for commercially insured prescriptions decreased from $10.83 to $8.90 from 2015-19. However, cash-paying patients without insurance are spending more, as their average monthly prescription cost increased to $50.78 from $36.77, and their average brand-name drug cost increased to $105.74 from $93.62.
The analysis also noted that 60 percent of all prescriptions with a final cost exceeding $500 are never picked up, compared to a 5 percent abandonment rate for prescriptions with no cost.
More articles on pharmacy:
Politicians should stay out of COVID-19 vaccine approval, health experts warn
Ban distracting music in drug ads, consumers advocates urge FDA
10 hospitals seeking pharmacy leaders
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
